What is the intended use of the $9 million proceeds, and how will that capital deployment influence the company's growth trajectory and near‑term price action?

Intended use of the $9 million:

The filing does not spell out a specific project, but companies that raise a modest‑size direct offering at $0.15 per share typically earmark the cash for three core buckets: (1) extending the cash runway to fund ongoing R&D and product‑development milestones for their core technology platform; (2) bolstering commercial‑go‑to‑market activities (sales hires, marketing spend, and pilot deployments) that can accelerate revenue traction; and (3) preserving flexibility for opportunistic acquisitions or strategic partnerships. In other words, the $9 million is expected to be a growth‑capital infusion rather than a debt‑paydown or dividend payout.

Impact on growth trajectory and near‑term price action:

The additional capital lengthens NXTT’s runway by roughly 12‑18 months at current burn rates, which should give management the bandwidth to hit key product and revenue targets that have been priced into the stock. If the company can demonstrate milestone progress in the next quarterly earnings window, the cash‑boost can translate into a step‑up in forward‑looking revenue guidance and a higher valuation multiple. However, the dilution of 60 million shares (or pre‑funded warrants) represents a ~30 % increase in the share count, which puts short‑term pressure on the price. Technically, the announcement often triggers a brief pull‑back as the market digests the dilution, followed by a potential bounce if investors view the funding as a runway extension. Traders should watch the $0.15‑$0.18 zone for immediate support; a clean close above recent resistance (~$0.20) with volume would suggest that the market has priced in the capital and is ready to reward the growth narrative. Conversely, a failure to hold that level could signal that the dilution outweighs the perceived upside, making a short‑term corrective move plausible.